Wilson Therapeutics AB (publ) Year-end Report 2016
Good year-end data gives a promising start to 2017October 1 – December 31, 2016 · Net sales amounted to SEK 0.0 M (0.0) · Loss for the period was SEK 34.1 M (loss: 21.3) · Loss per share, before and after dilution, totaled SEK 1.33 (loss: 16.84) · At December 31, cash and cash equivalents amounted to SEK 386.6 M (31.4) January 1 – December 31, 2016 · Net sales amounted to SEK 0.0 M (0.0) · Loss for the period was SEK 115.2 M (loss: 70.5) · Loss per share, before and after dilution, totaled SEK 6.84 (loss: 55.53) · The board of directors proposes that no